Analystreport

Sorrento Therapeutics Inc (NASDAQ: SRNE) is now covered by analysts at B. Riley. They set a "buy" rating and a $14.25 price target on the stock.

Sorrento Therapeutics, Inc.  (SRNE) 
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm Check Earnings Report
US:NASDAQ Investor Relations: sorrentotherapeutics.com/investors